Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
Holding NVCT?
Track your performance easily
Nuvectis Pharma (NVCT) Ownership Overview
34.15% Insiders
1.69% Mutual Funds
1.66% Other Institutional Investors
1.60% ETFs
60.90% Public Companies and
Individual Investors
The ownership structure of Nuvectis Pharma (NVCT) stock is a mix of institutional, retail, and individual investors. Approximately 4.95% of the company’s stock is owned by Institutional Investors, 34.15% is owned by Insiders, and 60.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 20, 2024 | Enrique Poradosu Chief Science & Business Off | xxxxxxxxxxxxx | $9980 |
| Nov 18, 2024 | Ron Bentsur Chairman & Ceo,director, >10% Owner | xxxxxxxxxxxxx | $98400 |
| Nov 08, 2024 | Michael J. Carson Vice President, Finance | xxxxxxxxxxxxx | $22453 |
| May 15, 2024 | Ron Bentsur Chairman & Ceo,director, >10% Owner | xxxxxxxxxxxxx | $13076 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,266,424 | Insider | 16.91% | 16,560,770 | |
| 1,506,319 | Insider | 7.80% | 7,637,037 | |
| 1,493,068 | Insider | 7.73% | 7,569,855 | |
| 288,070 | Institution | 1.49% | 1,460,515 | |
| 238,070 | Institution | 1.23% | 1,207,015 | |
| 103,140 | Insider | 0.53% | 522,920 | |
| 87,918 | Insider | 0.46% | 445,744 | |
| 83,760 | Insider | 0.43% | 424,663 | |
| 57,828 | Insider | 0.30% | 293,188 | |
| 48,535 | Institution | 0.25% | 246,072 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 238,070 | Institution | 1.23% | 1,207,015 | |
| 48,535 | Institution | 0.25% | 246,072 | |
| 9,280 | Institution | 0.05% | 47,050 | |
| 5,612 | Institution | 0.03% | 28,453 | |
| 5,600 | Institution | 0.03% | 28,392 | |
| 3,944 | Institution | 0.02% | 19,996 | |
| 3,645 | Institution | 0.02% | 18,480 | |
| 3,154 | Institution | 0.02% | 15,991 | |
| 2,330 | Institution | 0.01% | 11,813 | |
| 2,100 | Institution | 0.01% | 10,647 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 231,040 | Institution | 1.20% | 1,725,869 | |
| 57,030 | Institution | 0.30% | 426,014 | |
| 21,218 | Institution | 0.11% | 107,575 | |
| 724 | Institution | <0.01% | 6,704 |
FAQ
Who Owns Nuvectis Pharma (NVCT)?
According to the latest TipRanks data, approximately 1.66% of the company's stock is held by institutional investors, 34.15% is held by insiders, and 60.90% is held by retail investors.
What percentage of Nuvectis Pharma (NVCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.66% of Nuvectis Pharma (NVCT) stock is held by institutional investors.
What percentage of Nuvectis Pharma (NVCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.90% of Nuvectis Pharma (NVCT) stock is held by retail investors.
Who owns the most shares of Nuvectis Pharma (NVCT)?
Ron Bentsur owns the most shares of Nuvectis Pharma (NVCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.